Gilead Sciences Inc said on Tuesday it was in discussions with chemical and drug manufacturers to produce its experimental COVID-19 drug remdesivir for Europe, Asia and the developing world through at least 2022.from Moneycontrol World News https://bit.ly/2L0s4RU
No comments:
Post a Comment